FDG PET/CT in monitoring treatment of retroperitoneal fibrosis

Tarih
2012
Yazar
Asa, S.
Sonmezoglu, K.
Halac, M.
Tan, Y. Z.
Ozhan, M.
Yilmaz, S.
Üst veri
Tüm öğe kaydını göster
Özet
Retroperitoneal fibrosis is an uncommon disease characterized by inflammatory fibrosis typically surrounding abdominal aorta and iliac arteries. The glucose analogue F18-fluorodeoxyglucose can be used to image inflammatory cell activity non-invasively by PET. In this report we investigated the usefulness of the FDG PET/CT in the disease activity and therapy response evaluation of retroperitoneal fibrosis. (C) 2012 Elsevier Espana, S.L. and SEMNIM. All rights reserved.
Bağlantı
http://hdl.handle.net/20.500.12627/165996
https://doi.org/10.1016/j.remn.2012.04.001
Koleksiyonlar